Sign In
Buy COYA
Coya Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 5.11M and sold 0 COYA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 5.11M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Nov 11, 2024 Buy |
Swaminathan Arun Chief Executive Officer |
5 000 Value: $36.7K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
115 000 Value: $465.8K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
81 819 Value: $482.7K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
70 596 Value: $575.4K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
115 000 Value: $465.8K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
81 819 Value: $482.7K |
||
|
Aug 19, 2024 Buy |
Swaminathan Arun Director |
70 596 Value: $575.4K |
||
|
Jun 03, 2024 Buy |
Snyder David S Chief Financial Officer |
70 596 Value: $575.4K |
||
|
Jun 03, 2024 Buy |
Berman Howard Chief Executive Officer |
163 663 Value: $1.33M |
||
|
Jun 03, 2024 Buy |
Grossman Fred Chief Medical Officer |
70 596 Value: $575.4K |
||
|
Jun 03, 2024 Buy |
Snyder David S Chief Financial Officer |
70 596 Value: $575.4K |
||
|
Jun 03, 2024 Buy |
Berman Howard Chief Executive Officer |
163 663 Value: $1.33M |
||
|
Jun 03, 2024 Buy |
Grossman Fred Chief Medical Officer |
70 596 Value: $575.4K |
||
|
Jan 31, 2024 Buy |
Grossman Fred Chief Medical Officer |
81 819 Value: $482.7K |
||
|
Jan 31, 2024 Buy |
Grossman Fred Chief Medical Officer |
74 069 Value: $437.0K |
||
|
Jan 31, 2024 Buy |
Snyder David S Chief Financial Officer |
81 819 Value: $482.7K |
||
|
Jan 31, 2024 Buy |
Berman Howard Chief Executive Officer |
189 680 Value: $1.12M |
||
|
Jan 31, 2024 Buy |
Grossman Fred Chief Medical Officer |
81 819 Value: $482.7K |
||
|
Jan 31, 2024 Buy |
Grossman Fred Chief Medical Officer |
74 069 Value: $437.0K |
||
|
Jan 31, 2024 Buy |
Snyder David S Chief Financial Officer |
81 819 Value: $482.7K |
||
|
Jan 31, 2024 Buy |
Berman Howard Chief Executive Officer |
189 680 Value: $1.12M |
||
|
Jan 02, 2024 Buy |
Ross Wilbur L Jr Director |
10 000 Value: $69.7K |
||
|
Jan 02, 2024 Buy |
Ross Wilbur L Jr Director |
10 000 Value: $69.7K |
||
|
Jan 01, 2024 Buy |
Weinand Dieter Director |
5 000 Value: $37.1K |
||
|
Jan 01, 2024 Buy |
Garren Hideki Director |
5 000 Value: $37.1K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
